Alexander Kaizer
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Research Design | 11 | 2025 | 1139 | 2.430 |
Why?
| | Bayes Theorem | 12 | 2025 | 421 | 1.740 |
Why?
| | Laryngopharyngeal Reflux | 5 | 2025 | 14 | 1.680 |
Why?
| | Medical Futility | 2 | 2024 | 32 | 1.550 |
Why?
| | Atrioventricular Block | 5 | 2026 | 44 | 1.350 |
Why?
| | Heart Rate, Fetal | 3 | 2026 | 31 | 1.170 |
Why?
| | Models, Statistical | 5 | 2024 | 672 | 1.130 |
Why?
| | Gastroesophageal Reflux | 8 | 2024 | 237 | 1.060 |
Why?
| | Neoplasms | 6 | 2025 | 2913 | 0.990 |
Why?
| | Esophageal Sphincter, Upper | 2 | 2025 | 8 | 0.980 |
Why?
| | Cesarean Section | 4 | 2026 | 230 | 0.940 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1751 | 0.910 |
Why?
| | Long QT Syndrome | 2 | 2023 | 68 | 0.870 |
Why?
| | Bariatric Surgery | 7 | 2026 | 253 | 0.860 |
Why?
| | Antibiotic Prophylaxis | 1 | 2026 | 134 | 0.860 |
Why?
| | Neostigmine | 2 | 2026 | 21 | 0.850 |
Why?
| | Surgical Wound Infection | 2 | 2026 | 329 | 0.850 |
Why?
| | Data Interpretation, Statistical | 3 | 2024 | 368 | 0.840 |
Why?
| | Weight Loss | 9 | 2026 | 859 | 0.820 |
Why?
| | Preoperative Care | 2 | 2026 | 380 | 0.800 |
Why?
| | Computer Simulation | 4 | 2024 | 1003 | 0.760 |
Why?
| | Humans | 121 | 2026 | 145750 | 0.750 |
Why?
| | Ritonavir | 1 | 2022 | 75 | 0.730 |
Why?
| | Tobacco Products | 2 | 2020 | 84 | 0.690 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 65 | 0.680 |
Why?
| | Obesity, Morbid | 6 | 2020 | 293 | 0.670 |
Why?
| | Fetal Diseases | 5 | 2026 | 194 | 0.660 |
Why?
| | Multiple Pulmonary Nodules | 3 | 2026 | 23 | 0.650 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2022 | 238 | 0.630 |
Why?
| | Pediatric Obesity | 8 | 2020 | 638 | 0.570 |
Why?
| | Clinical Trials as Topic | 1 | 2024 | 1062 | 0.570 |
Why?
| | Data Collection | 1 | 2021 | 643 | 0.570 |
Why?
| | Esophageal Achalasia | 3 | 2023 | 29 | 0.570 |
Why?
| | Anti-Bacterial Agents | 4 | 2026 | 1925 | 0.570 |
Why?
| | Spinal Cord Stimulation | 3 | 2024 | 8 | 0.570 |
Why?
| | Anaphylaxis | 1 | 2020 | 102 | 0.560 |
Why?
| | Retrospective Studies | 35 | 2026 | 17322 | 0.550 |
Why?
| | Biostatistics | 1 | 2018 | 19 | 0.540 |
Why?
| | Therapeutics | 1 | 2018 | 14 | 0.540 |
Why?
| | Treatment Outcome | 20 | 2026 | 11793 | 0.510 |
Why?
| | Esophageal Motility Disorders | 3 | 2023 | 30 | 0.510 |
Why?
| | Clinical Protocols | 1 | 2018 | 280 | 0.470 |
Why?
| | Solitary Pulmonary Nodule | 2 | 2026 | 25 | 0.470 |
Why?
| | Antibodies, Antinuclear | 3 | 2022 | 62 | 0.470 |
Why?
| | Tobacco Use Disorder | 1 | 2018 | 217 | 0.470 |
Why?
| | Antiviral Agents | 1 | 2022 | 769 | 0.470 |
Why?
| | Prospective Studies | 23 | 2026 | 8075 | 0.470 |
Why?
| | Female | 60 | 2026 | 79025 | 0.460 |
Why?
| | Ixodidae | 1 | 2015 | 7 | 0.450 |
Why?
| | Analgesics, Opioid | 7 | 2025 | 1154 | 0.440 |
Why?
| | Mucopolysaccharidosis I | 3 | 2019 | 10 | 0.430 |
Why?
| | Lung Neoplasms | 5 | 2026 | 2667 | 0.420 |
Why?
| | Manometry | 7 | 2023 | 98 | 0.420 |
Why?
| | Larva | 1 | 2015 | 240 | 0.410 |
Why?
| | Adult | 35 | 2026 | 40867 | 0.410 |
Why?
| | Pepsin A | 3 | 2023 | 18 | 0.400 |
Why?
| | Sample Size | 3 | 2024 | 121 | 0.400 |
Why?
| | Esophagitis, Peptic | 2 | 2023 | 16 | 0.370 |
Why?
| | Pregnancy | 10 | 2026 | 7215 | 0.370 |
Why?
| | Anti-Obesity Agents | 3 | 2019 | 67 | 0.370 |
Why?
| | Esophageal pH Monitoring | 5 | 2023 | 22 | 0.360 |
Why?
| | Brachial Plexus Block | 2 | 2022 | 2 | 0.360 |
Why?
| | Speech Perception | 2 | 2026 | 91 | 0.360 |
Why?
| | Proton Pump Inhibitors | 6 | 2023 | 109 | 0.350 |
Why?
| | Injections, Spinal | 3 | 2025 | 120 | 0.350 |
Why?
| | Male | 50 | 2026 | 72992 | 0.350 |
Why?
| | Information Dissemination | 2 | 2024 | 224 | 0.330 |
Why?
| | Enteral Nutrition | 2 | 2025 | 217 | 0.330 |
Why?
| | Obesity | 5 | 2023 | 3118 | 0.320 |
Why?
| | Adaptive Clinical Trials as Topic | 2 | 2022 | 24 | 0.320 |
Why?
| | Cardiopulmonary Resuscitation | 2 | 2024 | 339 | 0.310 |
Why?
| | Anesthetics | 2 | 2022 | 100 | 0.310 |
Why?
| | Nerve Block | 3 | 2021 | 108 | 0.310 |
Why?
| | Body Contouring | 2 | 2020 | 9 | 0.310 |
Why?
| | Probability | 4 | 2023 | 308 | 0.300 |
Why?
| | Enzyme Replacement Therapy | 2 | 2019 | 15 | 0.300 |
Why?
| | Analgesia, Epidural | 2 | 2021 | 39 | 0.300 |
Why?
| | Biomarkers, Tumor | 3 | 2026 | 1329 | 0.300 |
Why?
| | Pain Management | 2 | 2025 | 411 | 0.290 |
Why?
| | Saliva | 3 | 2025 | 249 | 0.280 |
Why?
| | Aged | 20 | 2026 | 26212 | 0.270 |
Why?
| | Esophagus | 2 | 2020 | 262 | 0.270 |
Why?
| | Middle Aged | 23 | 2026 | 36297 | 0.260 |
Why?
| | Tomography, X-Ray Computed | 4 | 2026 | 2770 | 0.260 |
Why?
| | Hearing Aids | 3 | 2026 | 98 | 0.260 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2024 | 32 | 0.250 |
Why?
| | Surgeons | 2 | 2021 | 340 | 0.250 |
Why?
| | Histoplasma | 1 | 2026 | 11 | 0.240 |
Why?
| | Antibodies, Fungal | 1 | 2026 | 11 | 0.240 |
Why?
| | Incidence | 7 | 2026 | 2933 | 0.240 |
Why?
| | Anesthetics, Local | 3 | 2022 | 104 | 0.240 |
Why?
| | Nicotine | 2 | 2020 | 331 | 0.240 |
Why?
| | Hypoventilation | 1 | 2026 | 17 | 0.230 |
Why?
| | Infant | 10 | 2026 | 10089 | 0.230 |
Why?
| | Child | 19 | 2025 | 22738 | 0.230 |
Why?
| | Child Language | 1 | 2026 | 21 | 0.230 |
Why?
| | After-Hours Care | 1 | 2025 | 17 | 0.230 |
Why?
| | Cough | 2 | 2024 | 124 | 0.230 |
Why?
| | Bradycardia | 1 | 2026 | 61 | 0.230 |
Why?
| | Predictive Value of Tests | 4 | 2026 | 2123 | 0.230 |
Why?
| | Neuromuscular Blockade | 1 | 2026 | 53 | 0.220 |
Why?
| | Fractures, Multiple | 1 | 2025 | 6 | 0.220 |
Why?
| | Language Development | 1 | 2026 | 59 | 0.220 |
Why?
| | Bupivacaine | 2 | 2022 | 41 | 0.220 |
Why?
| | Micrognathism | 1 | 2025 | 19 | 0.220 |
Why?
| | Pierre Robin Syndrome | 1 | 2025 | 16 | 0.220 |
Why?
| | Osteogenesis, Distraction | 1 | 2025 | 25 | 0.220 |
Why?
| | Mandible | 1 | 2025 | 73 | 0.210 |
Why?
| | Adrenergic beta-Antagonists | 2 | 2023 | 252 | 0.210 |
Why?
| | Airway Management | 1 | 2025 | 81 | 0.210 |
Why?
| | Recurrent Laryngeal Nerve Injuries | 1 | 2024 | 16 | 0.210 |
Why?
| | Cancer Pain | 1 | 2025 | 39 | 0.210 |
Why?
| | Multicenter Studies as Topic | 2 | 2026 | 413 | 0.210 |
Why?
| | Body Weight | 2 | 2019 | 972 | 0.210 |
Why?
| | Infant, Newborn | 7 | 2026 | 6464 | 0.210 |
Why?
| | Biometry | 1 | 2024 | 66 | 0.200 |
Why?
| | Laparoscopy | 2 | 2020 | 481 | 0.200 |
Why?
| | Pregnancy Outcome | 3 | 2023 | 504 | 0.200 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2024 | 21 | 0.200 |
Why?
| | Patient Reported Outcome Measures | 2 | 2025 | 498 | 0.200 |
Why?
| | Hearing Loss, Sudden | 1 | 2023 | 12 | 0.200 |
Why?
| | Radiation Dosage | 1 | 2025 | 193 | 0.200 |
Why?
| | Myotomy | 1 | 2023 | 15 | 0.190 |
Why?
| | Airway Obstruction | 1 | 2025 | 153 | 0.190 |
Why?
| | Blood Transfusion | 2 | 2024 | 409 | 0.190 |
Why?
| | Tachycardia, Supraventricular | 1 | 2023 | 49 | 0.190 |
Why?
| | Atrial Flutter | 1 | 2023 | 47 | 0.190 |
Why?
| | Postoperative Care | 1 | 2025 | 286 | 0.190 |
Why?
| | Intestinal Atresia | 1 | 2023 | 17 | 0.190 |
Why?
| | Intrauterine Devices, Medicated | 1 | 2023 | 27 | 0.190 |
Why?
| | Adolescent | 19 | 2026 | 22569 | 0.190 |
Why?
| | Lopinavir | 1 | 2022 | 30 | 0.190 |
Why?
| | Vitamin D Deficiency | 1 | 2025 | 190 | 0.190 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2023 | 73 | 0.190 |
Why?
| | Heart Arrest | 2 | 2024 | 411 | 0.190 |
Why?
| | Immunosorbents | 1 | 2022 | 1 | 0.180 |
Why?
| | Lidocaine | 1 | 2023 | 55 | 0.180 |
Why?
| | Point-of-Care Systems | 1 | 2024 | 189 | 0.180 |
Why?
| | Neutropenia | 1 | 2023 | 154 | 0.180 |
Why?
| | Intubation, Intratracheal | 1 | 2025 | 327 | 0.180 |
Why?
| | Fetal Heart | 2 | 2019 | 56 | 0.180 |
Why?
| | Equivalence Trials as Topic | 1 | 2022 | 35 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2025 | 277 | 0.180 |
Why?
| | Current Procedural Terminology | 1 | 2022 | 19 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.180 |
Why?
| | Triage | 1 | 2024 | 250 | 0.180 |
Why?
| | Tympanoplasty | 1 | 2022 | 9 | 0.180 |
Why?
| | Electromyography | 1 | 2024 | 419 | 0.180 |
Why?
| | United States | 10 | 2025 | 16122 | 0.180 |
Why?
| | Weight Gain | 1 | 2026 | 561 | 0.180 |
Why?
| | Tympanic Membrane Perforation | 1 | 2022 | 18 | 0.180 |
Why?
| | Diaphragm | 2 | 2022 | 48 | 0.180 |
Why?
| | Tremor | 1 | 2022 | 98 | 0.170 |
Why?
| | Enterocolitis, Neutropenic | 1 | 2021 | 5 | 0.170 |
Why?
| | Funnel Chest | 1 | 2021 | 29 | 0.170 |
Why?
| | Psychological Trauma | 1 | 2022 | 57 | 0.170 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2022 | 68 | 0.170 |
Why?
| | Lung | 3 | 2024 | 4116 | 0.170 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2022 | 133 | 0.170 |
Why?
| | Vitamin D | 1 | 2025 | 404 | 0.170 |
Why?
| | Nose Neoplasms | 1 | 2021 | 22 | 0.170 |
Why?
| | Eructation | 1 | 2021 | 2 | 0.170 |
Why?
| | Prostate | 1 | 2022 | 159 | 0.170 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2021 | 29 | 0.170 |
Why?
| | Medicare Part D | 1 | 2021 | 23 | 0.170 |
Why?
| | Epidermolysis Bullosa | 1 | 2022 | 69 | 0.170 |
Why?
| | Telemedicine | 2 | 2021 | 963 | 0.170 |
Why?
| | Fetus | 2 | 2023 | 804 | 0.170 |
Why?
| | Hernia, Hiatal | 1 | 2021 | 39 | 0.170 |
Why?
| | Congenital Microtia | 1 | 2020 | 8 | 0.170 |
Why?
| | Tumor Burden | 1 | 2022 | 325 | 0.160 |
Why?
| | Patient Handoff | 1 | 2021 | 44 | 0.160 |
Why?
| | Prenatal Diagnosis | 2 | 2019 | 196 | 0.160 |
Why?
| | Cystectomy | 1 | 2021 | 42 | 0.160 |
Why?
| | Specialties, Surgical | 1 | 2022 | 82 | 0.160 |
Why?
| | Ear | 1 | 2020 | 31 | 0.160 |
Why?
| | Bias | 1 | 2021 | 197 | 0.160 |
Why?
| | Risk Factors | 11 | 2025 | 10916 | 0.160 |
Why?
| | Postoperative Complications | 4 | 2021 | 2977 | 0.160 |
Why?
| | Body Mass Index | 5 | 2026 | 2447 | 0.160 |
Why?
| | Hepatectomy | 1 | 2023 | 274 | 0.160 |
Why?
| | Ocular Hypertension | 1 | 2021 | 70 | 0.160 |
Why?
| | Spinal Cord Injuries | 1 | 2024 | 235 | 0.160 |
Why?
| | Shock | 1 | 2021 | 110 | 0.160 |
Why?
| | Electrocardiography | 1 | 2023 | 668 | 0.160 |
Why?
| | Magnetocardiography | 1 | 2019 | 2 | 0.150 |
Why?
| | Parenteral Nutrition | 1 | 2021 | 102 | 0.150 |
Why?
| | Cardiovascular Diseases | 3 | 2023 | 2190 | 0.150 |
Why?
| | Drug Costs | 1 | 2021 | 117 | 0.150 |
Why?
| | Prevalence | 3 | 2023 | 2874 | 0.150 |
Why?
| | Glaucoma, Open-Angle | 1 | 2021 | 104 | 0.150 |
Why?
| | Carcinoma | 1 | 2021 | 227 | 0.150 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2026 | 992 | 0.150 |
Why?
| | Congenital Abnormalities | 1 | 2020 | 109 | 0.150 |
Why?
| | Time Factors | 7 | 2026 | 7133 | 0.150 |
Why?
| | Substance Abuse Detection | 1 | 2021 | 110 | 0.150 |
Why?
| | Quality Improvement | 2 | 2026 | 1296 | 0.150 |
Why?
| | Hearing Loss | 1 | 2023 | 249 | 0.150 |
Why?
| | Cochlear Implantation | 1 | 2021 | 83 | 0.150 |
Why?
| | Tracheostomy | 1 | 2021 | 142 | 0.150 |
Why?
| | Cochlear Implants | 1 | 2021 | 96 | 0.150 |
Why?
| | Hyperplasia | 1 | 2020 | 177 | 0.150 |
Why?
| | Kidney Transplantation | 1 | 2026 | 712 | 0.150 |
Why?
| | Spine | 1 | 2021 | 182 | 0.150 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 18 | 0.140 |
Why?
| | Cardiotocography | 1 | 2018 | 5 | 0.140 |
Why?
| | Exercise | 3 | 2020 | 2203 | 0.140 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2019 | 63 | 0.140 |
Why?
| | Stillbirth | 1 | 2019 | 82 | 0.140 |
Why?
| | Medically Underserved Area | 1 | 2019 | 100 | 0.140 |
Why?
| | Drug Prescriptions | 1 | 2021 | 288 | 0.140 |
Why?
| | Intra-Abdominal Fat | 1 | 2019 | 101 | 0.140 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2022 | 258 | 0.140 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2018 | 9 | 0.140 |
Why?
| | Cell-Derived Microparticles | 1 | 2019 | 73 | 0.140 |
Why?
| | Soaps | 1 | 2018 | 10 | 0.140 |
Why?
| | Abortion, Spontaneous | 1 | 2019 | 119 | 0.140 |
Why?
| | Baths | 1 | 2018 | 14 | 0.140 |
Why?
| | Child, Preschool | 9 | 2026 | 11866 | 0.140 |
Why?
| | Genotype | 1 | 2023 | 1857 | 0.140 |
Why?
| | Outpatients | 1 | 2022 | 447 | 0.140 |
Why?
| | Nutritional Status | 1 | 2021 | 353 | 0.140 |
Why?
| | Postoperative Nausea and Vomiting | 1 | 2018 | 24 | 0.140 |
Why?
| | Anesthesia | 1 | 2022 | 257 | 0.140 |
Why?
| | Anti-Infective Agents, Local | 1 | 2018 | 40 | 0.140 |
Why?
| | Africa, Western | 1 | 2018 | 21 | 0.140 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 440 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4569 | 0.130 |
Why?
| | Cannabinoids | 1 | 2020 | 184 | 0.130 |
Why?
| | Phenotype | 2 | 2023 | 3170 | 0.130 |
Why?
| | Gastroenterology | 1 | 2020 | 191 | 0.130 |
Why?
| | Glaucoma | 1 | 2021 | 251 | 0.130 |
Why?
| | Perioperative Care | 1 | 2020 | 231 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2024 | 611 | 0.130 |
Why?
| | Ultrasonography, Prenatal | 1 | 2019 | 295 | 0.130 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2017 | 56 | 0.130 |
Why?
| | Cross-Sectional Studies | 7 | 2025 | 5921 | 0.130 |
Why?
| | Penicillin Resistance | 1 | 2017 | 9 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2019 | 184 | 0.130 |
Why?
| | Barrett Esophagus | 1 | 2020 | 169 | 0.130 |
Why?
| | Hemorrhagic Fever, Ebola | 1 | 2018 | 82 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 1 | 2018 | 137 | 0.130 |
Why?
| | Hypoxia | 2 | 2025 | 1199 | 0.130 |
Why?
| | Serogroup | 1 | 2017 | 45 | 0.130 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2026 | 1191 | 0.120 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 154 | 0.120 |
Why?
| | Child Behavior | 1 | 2019 | 236 | 0.120 |
Why?
| | Disinfection | 1 | 2018 | 131 | 0.120 |
Why?
| | Phentermine | 1 | 2016 | 14 | 0.120 |
Why?
| | Swine | 3 | 2024 | 826 | 0.120 |
Why?
| | Echocardiography | 1 | 2019 | 648 | 0.120 |
Why?
| | Cigarette Smoking | 1 | 2018 | 102 | 0.120 |
Why?
| | Ovarian Neoplasms | 1 | 2022 | 595 | 0.120 |
Why?
| | Blood Platelets | 1 | 2019 | 379 | 0.120 |
Why?
| | Aortic Valve Stenosis | 1 | 2019 | 256 | 0.120 |
Why?
| | Respiration, Artificial | 1 | 2021 | 714 | 0.120 |
Why?
| | Pneumococcal Infections | 1 | 2017 | 104 | 0.120 |
Why?
| | Fructose | 1 | 2016 | 132 | 0.120 |
Why?
| | Heart-Assist Devices | 1 | 2022 | 568 | 0.120 |
Why?
| | Parkinson Disease | 1 | 2022 | 601 | 0.120 |
Why?
| | Pneumonectomy | 1 | 2017 | 167 | 0.120 |
Why?
| | Burns | 1 | 2021 | 374 | 0.120 |
Why?
| | Spinal Cord | 3 | 2024 | 382 | 0.120 |
Why?
| | Gestational Age | 4 | 2019 | 989 | 0.110 |
Why?
| | Body Composition | 1 | 2019 | 693 | 0.110 |
Why?
| | Adiposity | 2 | 2019 | 532 | 0.110 |
Why?
| | Internal Medicine | 1 | 2018 | 279 | 0.110 |
Why?
| | Heart Transplantation | 1 | 2022 | 680 | 0.110 |
Why?
| | Mentoring | 1 | 2018 | 166 | 0.110 |
Why?
| | Missouri | 1 | 2015 | 66 | 0.110 |
Why?
| | Pain Measurement | 3 | 2025 | 562 | 0.110 |
Why?
| | Reproducibility of Results | 5 | 2021 | 3416 | 0.110 |
Why?
| | Meals | 1 | 2016 | 130 | 0.110 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 251 | 0.110 |
Why?
| | Forests | 1 | 2015 | 48 | 0.110 |
Why?
| | Lung Diseases | 1 | 2022 | 782 | 0.110 |
Why?
| | Streptococcus pneumoniae | 1 | 2017 | 186 | 0.110 |
Why?
| | Faculty, Medical | 1 | 2018 | 305 | 0.110 |
Why?
| | Suicide | 1 | 2022 | 729 | 0.110 |
Why?
| | Disease Outbreaks | 1 | 2018 | 419 | 0.110 |
Why?
| | Precision Medicine | 1 | 2019 | 461 | 0.110 |
Why?
| | Critical Illness | 1 | 2021 | 900 | 0.100 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2019 | 699 | 0.100 |
Why?
| | Length of Stay | 4 | 2021 | 1350 | 0.100 |
Why?
| | Epinephrine | 2 | 2026 | 158 | 0.100 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 6084 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 890 | 0.100 |
Why?
| | Pilot Projects | 4 | 2021 | 1897 | 0.100 |
Why?
| | Cognitive Dysfunction | 1 | 2019 | 468 | 0.100 |
Why?
| | Hypertension | 1 | 2022 | 1276 | 0.100 |
Why?
| | Wounds and Injuries | 1 | 2022 | 962 | 0.100 |
Why?
| | Mothers | 1 | 2019 | 765 | 0.100 |
Why?
| | Veterans | 2 | 2022 | 1639 | 0.100 |
Why?
| | Feeding Behavior | 1 | 2019 | 691 | 0.100 |
Why?
| | Cannabis | 1 | 2020 | 510 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 956 | 0.090 |
Why?
| | Esophagogastric Junction | 2 | 2023 | 55 | 0.090 |
Why?
| | Muscle Spasticity | 2 | 2023 | 63 | 0.090 |
Why?
| | Pregnancy Complications | 1 | 2018 | 603 | 0.090 |
Why?
| | Minnesota | 3 | 2018 | 168 | 0.090 |
Why?
| | Medicare | 3 | 2024 | 904 | 0.090 |
Why?
| | Quality of Life | 1 | 2025 | 3210 | 0.090 |
Why?
| | Seasons | 1 | 2015 | 538 | 0.090 |
Why?
| | Opioid-Related Disorders | 1 | 2021 | 605 | 0.090 |
Why?
| | Animals | 5 | 2024 | 38100 | 0.090 |
Why?
| | Physicians | 1 | 2021 | 956 | 0.090 |
Why?
| | Clinical Competence | 1 | 2020 | 1247 | 0.090 |
Why?
| | Electric Impedance | 2 | 2023 | 108 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2020 | 1244 | 0.090 |
Why?
| | Hospitalization | 1 | 2022 | 2460 | 0.090 |
Why?
| | Heartburn | 2 | 2021 | 12 | 0.090 |
Why?
| | Heart Defects, Congenital | 1 | 2019 | 910 | 0.090 |
Why?
| | Monitoring, Ambulatory | 2 | 2023 | 89 | 0.090 |
Why?
| | Mental Health | 1 | 2018 | 796 | 0.080 |
Why?
| | Internship and Residency | 1 | 2022 | 1269 | 0.080 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2023 | 532 | 0.080 |
Why?
| | Ecosystem | 1 | 2015 | 478 | 0.080 |
Why?
| | ROC Curve | 2 | 2024 | 618 | 0.080 |
Why?
| | Intensive Care Units | 3 | 2021 | 924 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2219 | 0.080 |
Why?
| | Cognition | 1 | 2019 | 1271 | 0.080 |
Why?
| | Anxiety | 1 | 2018 | 1122 | 0.080 |
Why?
| | Cohort Studies | 4 | 2021 | 6032 | 0.080 |
Why?
| | Longitudinal Studies | 3 | 2026 | 2967 | 0.080 |
Why?
| | Operating Rooms | 2 | 2022 | 144 | 0.080 |
Why?
| | Operative Time | 2 | 2022 | 181 | 0.070 |
Why?
| | Tertiary Care Centers | 2 | 2022 | 195 | 0.070 |
Why?
| | Medical Oncology | 2 | 2022 | 340 | 0.070 |
Why?
| | Hemodynamics | 2 | 2024 | 1118 | 0.070 |
Why?
| | Prognosis | 3 | 2023 | 4329 | 0.070 |
Why?
| | Ultrasonography, Interventional | 2 | 2021 | 166 | 0.070 |
Why?
| | Depression | 1 | 2018 | 1557 | 0.070 |
Why?
| | Sensitivity and Specificity | 2 | 2023 | 2000 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2026 | 2064 | 0.060 |
Why?
| | Anesthesia Recovery Period | 1 | 2026 | 28 | 0.060 |
Why?
| | Speech Discrimination Tests | 1 | 2026 | 6 | 0.060 |
Why?
| | Phonetics | 1 | 2026 | 39 | 0.060 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2026 | 33 | 0.060 |
Why?
| | Cholinesterase Inhibitors | 1 | 2026 | 47 | 0.060 |
Why?
| | Umbilical Cord | 1 | 2026 | 93 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5428 | 0.060 |
Why?
| | Preoperative Period | 1 | 2026 | 149 | 0.060 |
Why?
| | Feasibility Studies | 2 | 2022 | 1115 | 0.060 |
Why?
| | Speech | 1 | 2026 | 76 | 0.060 |
Why?
| | Algorithms | 2 | 2024 | 1850 | 0.050 |
Why?
| | Decompression | 1 | 2024 | 3 | 0.050 |
Why?
| | Mice | 1 | 2022 | 18357 | 0.050 |
Why?
| | False Negative Reactions | 1 | 2024 | 61 | 0.050 |
Why?
| | Registries | 2 | 2025 | 2410 | 0.050 |
Why?
| | Uncertainty | 1 | 2025 | 146 | 0.050 |
Why?
| | Monitoring, Intraoperative | 1 | 2024 | 66 | 0.050 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2025 | 122 | 0.050 |
Why?
| | Disease Progression | 2 | 2024 | 2865 | 0.050 |
Why?
| | Ventricular Fibrillation | 1 | 2024 | 64 | 0.050 |
Why?
| | Quality Control | 1 | 2024 | 161 | 0.050 |
Why?
| | Neck | 1 | 2024 | 109 | 0.050 |
Why?
| | Laryngeal Diseases | 1 | 2024 | 31 | 0.050 |
Why?
| | Patient Positioning | 1 | 2024 | 70 | 0.050 |
Why?
| | Larynx | 1 | 2024 | 56 | 0.050 |
Why?
| | Hydrops Fetalis | 1 | 2023 | 13 | 0.050 |
Why?
| | Digoxin | 1 | 2023 | 27 | 0.050 |
Why?
| | Esophageal Sphincter, Lower | 1 | 2023 | 14 | 0.050 |
Why?
| | Tachycardia | 1 | 2023 | 58 | 0.050 |
Why?
| | Caregivers | 2 | 2023 | 1073 | 0.050 |
Why?
| | Anesthesia, General | 1 | 2024 | 121 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1711 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3634 | 0.050 |
Why?
| | Edema | 1 | 2023 | 125 | 0.050 |
Why?
| | Anti-Arrhythmia Agents | 1 | 2023 | 144 | 0.050 |
Why?
| | Fingers | 1 | 2022 | 107 | 0.040 |
Why?
| | Coronary Artery Bypass | 1 | 2024 | 268 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2022 | 123 | 0.040 |
Why?
| | Proton Pumps | 1 | 2021 | 8 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2022 | 173 | 0.040 |
Why?
| | Patients | 1 | 2023 | 183 | 0.040 |
Why?
| | Rotator Cuff | 1 | 2022 | 59 | 0.040 |
Why?
| | Goals | 1 | 2023 | 185 | 0.040 |
Why?
| | Motor Skills | 1 | 2022 | 104 | 0.040 |
Why?
| | Malawi | 1 | 2021 | 57 | 0.040 |
Why?
| | Prostheses and Implants | 1 | 2022 | 137 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 501 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2023 | 219 | 0.040 |
Why?
| | Tonometry, Ocular | 1 | 2021 | 104 | 0.040 |
Why?
| | Hearing Loss, Conductive | 1 | 2020 | 24 | 0.040 |
Why?
| | Benchmarking | 1 | 2022 | 191 | 0.040 |
Why?
| | Ultrasonography | 1 | 2024 | 788 | 0.040 |
Why?
| | Gastrointestinal Agents | 1 | 2021 | 65 | 0.040 |
Why?
| | Fitness Trackers | 1 | 2020 | 17 | 0.040 |
Why?
| | United Arab Emirates | 1 | 2020 | 6 | 0.040 |
Why?
| | Noise | 1 | 2021 | 72 | 0.040 |
Why?
| | Developmental Disabilities | 1 | 2023 | 281 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 228 | 0.040 |
Why?
| | Iduronidase | 1 | 2019 | 3 | 0.040 |
Why?
| | Ultrasonography, Doppler, Pulsed | 1 | 2019 | 7 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 73 | 0.040 |
Why?
| | Risk Assessment | 2 | 2020 | 3752 | 0.040 |
Why?
| | Abdominoplasty | 1 | 2019 | 7 | 0.040 |
Why?
| | Waist Circumference | 1 | 2020 | 143 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 52 | 0.040 |
Why?
| | Competency-Based Education | 1 | 2020 | 81 | 0.040 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2019 | 23 | 0.040 |
Why?
| | Iron | 1 | 2022 | 359 | 0.040 |
Why?
| | Piperidines | 1 | 2021 | 222 | 0.040 |
Why?
| | Biomarkers, Pharmacological | 1 | 2019 | 26 | 0.040 |
Why?
| | Collagen | 1 | 2022 | 457 | 0.040 |
Why?
| | Reoperation | 1 | 2022 | 637 | 0.040 |
Why?
| | Fathers | 1 | 2019 | 53 | 0.040 |
Why?
| | Biomarkers | 2 | 2021 | 4302 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2023 | 532 | 0.040 |
Why?
| | Colorado | 2 | 2019 | 4556 | 0.040 |
Why?
| | Child Abuse | 1 | 2025 | 553 | 0.040 |
Why?
| | Glycosaminoglycans | 1 | 2019 | 79 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 466 | 0.040 |
Why?
| | Intraocular Pressure | 1 | 2021 | 330 | 0.040 |
Why?
| | Mupirocin | 1 | 2018 | 7 | 0.040 |
Why?
| | Mouthwashes | 1 | 2018 | 13 | 0.040 |
Why?
| | Heterozygote | 1 | 2019 | 314 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2020 | 782 | 0.030 |
Why?
| | Chlorhexidine | 1 | 2018 | 23 | 0.030 |
Why?
| | Endoscopy, Digestive System | 1 | 2020 | 142 | 0.030 |
Why?
| | Hemorrhage | 1 | 2024 | 822 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2020 | 268 | 0.030 |
Why?
| | Administration, Intranasal | 1 | 2018 | 94 | 0.030 |
Why?
| | Early Detection of Cancer | 1 | 2023 | 486 | 0.030 |
Why?
| | Analgesics | 1 | 2020 | 231 | 0.030 |
Why?
| | Precancerous Conditions | 1 | 2020 | 166 | 0.030 |
Why?
| | Patient Care Bundles | 1 | 2018 | 29 | 0.030 |
Why?
| | Superficial Back Muscles | 1 | 2018 | 16 | 0.030 |
Why?
| | Self Administration | 1 | 2018 | 122 | 0.030 |
Why?
| | Nasal Cavity | 1 | 2018 | 61 | 0.030 |
Why?
| | Catheters | 1 | 2018 | 74 | 0.030 |
Why?
| | Carrier State | 1 | 2018 | 78 | 0.030 |
Why?
| | Chronic Disease | 1 | 2024 | 1810 | 0.030 |
Why?
| | Mortality | 1 | 2020 | 380 | 0.030 |
Why?
| | Endoscopy, Gastrointestinal | 1 | 2020 | 237 | 0.030 |
Why?
| | Staff Development | 1 | 2018 | 63 | 0.030 |
Why?
| | Comorbidity | 1 | 2022 | 1662 | 0.030 |
Why?
| | Endoscopy | 1 | 2020 | 317 | 0.030 |
Why?
| | Postoperative Period | 1 | 2018 | 351 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2021 | 712 | 0.030 |
Why?
| | Lipoproteins, VLDL | 1 | 2016 | 21 | 0.030 |
Why?
| | Risk | 1 | 2019 | 923 | 0.030 |
Why?
| | Africa | 1 | 2017 | 119 | 0.030 |
Why?
| | Body Constitution | 1 | 2016 | 51 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 14250 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2019 | 356 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2019 | 644 | 0.030 |
Why?
| | Fellowships and Scholarships | 1 | 2020 | 354 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2019 | 1368 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2021 | 1038 | 0.030 |
Why?
| | Diet, Reducing | 1 | 2016 | 91 | 0.030 |
Why?
| | Birth Weight | 1 | 2019 | 517 | 0.030 |
Why?
| | Time-to-Treatment | 1 | 2018 | 251 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1327 | 0.030 |
Why?
| | Aortic Valve | 1 | 2019 | 364 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2023 | 947 | 0.030 |
Why?
| | Absorptiometry, Photon | 1 | 2016 | 277 | 0.030 |
Why?
| | Premature Birth | 1 | 2019 | 390 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2016 | 114 | 0.030 |
Why?
| | Education, Medical | 1 | 2018 | 276 | 0.030 |
Why?
| | Risk Reduction Behavior | 1 | 2016 | 217 | 0.030 |
Why?
| | Military Personnel | 1 | 2022 | 737 | 0.030 |
Why?
| | Databases, Factual | 1 | 2020 | 1491 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 2094 | 0.030 |
Why?
| | Liver | 1 | 2023 | 1899 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2018 | 393 | 0.030 |
Why?
| | Fetal Growth Retardation | 1 | 2019 | 593 | 0.020 |
Why?
| | Behavior Therapy | 1 | 2016 | 296 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2139 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2024 | 2383 | 0.020 |
Why?
| | Primary Health Care | 1 | 2023 | 1736 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1791 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 1101 | 0.020 |
Why?
| | Parents | 1 | 2019 | 1404 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1278 | 0.020 |
Why?
| | Insulin | 1 | 2020 | 2516 | 0.020 |
Why?
|
|
Kaizer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|